Cargando…
Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act
BACKGROUND: The Ryan Haight Act generally requires a clinician to conduct an in-person visit before prescribing an opioid use disorder (OUD) medication. This requirement has impeded use of telemedicine to expand OUD treatment, and many policymakers have called for its removal. During the COVID-19 pa...
Autores principales: | Huskamp, Haiden A., Riedel, Lauren, Uscher-Pines, Lori, Busch, Alisa B., Barnett, Michael L., Raja, Pushpa, Mehrotra, Ateev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553288/ https://www.ncbi.nlm.nih.gov/pubmed/34713386 http://dx.doi.org/10.1007/s11606-021-07174-w |
Ejemplares similares
-
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine()
por: Uscher-Pines, Lori, et al.
Publicado: (2020) -
Adoption of telemedicine services by substance abuse treatment facilities in the U.S.
por: Uscher-Pines, Lori, et al.
Publicado: (2020) -
Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians
por: Huskamp, Haiden A., et al.
Publicado: (2023) -
Association Between Telemedicine Use in Nonmetropolitan Counties and Quality of Care Received by Medicare Beneficiaries With Serious Mental Illness
por: Wang, Bill, et al.
Publicado: (2022) -
Trends in Outpatient Telemedicine Utilization Among Rural Medicare Beneficiaries, 2010 to 2019
por: Barnett, Michael L., et al.
Publicado: (2021)